Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated May 21, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apellis Pharmaceuticals, Inc.
| 24.5K |
$3.76 | $92,120.00 | +2.20% | 1.14M |
May 20
| |||||||
Apellis Pharmaceuticals, Inc.
|
0
|
$23.33 | -$3,001,758.84 |
—
| 1.12M |
May 8
|
Scheduled
| ||||||
Apellis Pharmaceuticals, Inc.
|
0
|
$28.97 | -$3,483,762.90 |
—
| 1.12M |
Apr 8
|
Scheduled
| ||||||
Apellis Pharmaceuticals, Inc.
|
0
|
$32.93 | -$4,043,926.49 |
—
| 1.12M |
Mar 8
|
Scheduled
| ||||||
Apellis Pharmaceuticals, Inc.
| -1.15K |
$67.77 | -$77,796.40 | -0.10% | 1.12M |
Feb 12
| |||||||
Apellis Pharmaceuticals, Inc.
| -874.00 |
$64.14 | -$56,056.79 | -0.08% | 1.12M |
Jan 29
| |||||||
Apellis Pharmaceuticals, Inc.
| -3.91K |
$65.00 | -$254,329.35 | -0.35% | 1.12M |
Jan 22
| |||||||
Apellis Pharmaceuticals, Inc.
| 5.11K |
$66.81 | -$109,031.64 | +0.46% | 1.12M |
Jan 16
| |||||||
Apellis Pharmaceuticals, Inc.
| 45K |
$3.76 | $169,200.00 | +4.20% | 1.12M |
Nov 14
| |||||||
Apellis Pharmaceuticals, Inc.
| 5.49K |
$24.97 | -$520,531.02 | +0.52% | 1.07M |
Nov 8
|
Scheduled
| ||||||
Apellis Pharmaceuticals, Inc.
| 6.5K |
$21.53 | -$435,165.00 | +0.61% | 1.07M |
Oct 9
| |||||||
Apellis Pharmaceuticals, Inc.
| 6.5K |
$22.77 | -$465,045.00 | +0.62% | 1.06M |
Sep 8
| |||||||
Apellis Pharmaceuticals, Inc.
| 6.5K |
$13.17 | -$234,525.00 | +0.62% | 1.05M |
Aug 8
| |||||||
Apellis Pharmaceuticals, Inc.
| 6.5K |
$43.61 | -$965,205.00 | +0.62% | 1.05M |
Jul 10
| |||||||
Apellis Pharmaceuticals, Inc.
| 6.5K |
$47.01 | -$1,046,805.00 | +0.63% | 1.04M |
Jun 8
| |||||||
Apellis Pharmaceuticals, Inc.
| 6.5K |
$47.53 | -$1,059,285.00 | +0.63% | 1.03M |
May 8
| |||||||
Apellis Pharmaceuticals, Inc.
| 6.5K |
$40.44 | -$889,125.00 | +0.64% | 1.03M |
Apr 10
| |||||||
Apellis Pharmaceuticals, Inc.
| 6.5K |
$33.23 | -$716,085.00 | +0.64% | 1.02M |
Mar 8
| |||||||
Apellis Pharmaceuticals, Inc.
| 8.69K |
$58.50 | -$69,907.50 | +0.86% | 1.01M |
Feb 21
| |||||||
Apellis Pharmaceuticals, Inc.
| -1.13K |
$51.21 | -$58,072.14 | -0.11% | 1.01M |
Feb 10
| |||||||
Apellis Pharmaceuticals, Inc.
| 6.5K |
$28.56 | -$604,005.00 | +0.65% | 1.01M |
Feb 8
| |||||||
Apellis Pharmaceuticals, Inc.
| -832.00 |
$52.77 | -$43,904.64 | -0.08% | 1M |
Jan 27
| |||||||
Apellis Pharmaceuticals, Inc.
| -2.33K |
$52.05 | -$121,068.30 | -0.23% | 1M |
Jan 20
| |||||||
Apellis Pharmaceuticals, Inc.
| 19.63K |
—
|
—
| +2.00% | 1M |
Jan 12
| |||||||
Apellis Pharmaceuticals, Inc.
| 6.5K |
$24.38 | -$503,565.00 | +0.67% | 983.78K |
Jan 9
| |||||||
Apellis Pharmaceuticals, Inc.
| 7K |
$3.67 | $25,690.00 | +0.72% | 977.28K |
Dec 29
| |||||||
Apellis Pharmaceuticals, Inc.
| 6.5K |
$25.09 | -$520,605.00 | +0.67% | 970.28K |
Dec 8
| |||||||
Apellis Pharmaceuticals, Inc.
| 6.5K |
$24.57 | -$508,245.00 | +0.68% | 963.78K |
Nov 8
|
Scheduled
| ||||||
Apellis Pharmaceuticals, Inc.
| 6.5K |
$30.09 | -$640,605.00 | +0.68% | 957.28K |
Oct 10
| |||||||
Apellis Pharmaceuticals, Inc.
| 6.5K |
$33.32 | -$718,365.00 | +0.69% | 950.78K |
Sep 8
| |||||||
Apellis Pharmaceuticals, Inc.
| 6.5K |
$32.59 | -$700,605.00 | +0.69% | 944.28K |
Aug 8
| |||||||
Apellis Pharmaceuticals, Inc.
| 6.5K |
$25.31 | -$526,005.00 | +0.70% | 937.78K |
Jul 8
| |||||||
Apellis Pharmaceuticals, Inc.
| 33.01K |
$2.67 | $88,123.35 | +3.67% | 931.28K |
Jun 17
| |||||||
Apellis Pharmaceuticals, Inc.
| 6.5K |
$23.38 | -$479,685.00 | +0.73% | 898.27K |
Jun 8
| |||||||
Apellis Pharmaceuticals, Inc.
| -1.88K |
$23.55 | -$167,040.00 | -0.21% | 891.77K |
Apr 21 - Apr 29
| |||||||
Apellis Pharmaceuticals, Inc.
| -1.06K |
$47.12 | -$49,805.84 | -0.12% | 893.65K |
Feb 10
| |||||||
Apellis Pharmaceuticals, Inc.
| -931.00 |
$38.59 | -$35,927.29 | -0.10% | 894.71K |
Jan 28
| |||||||
Apellis Pharmaceuticals, Inc.
| 26.05K |
—
|
—
| +3.00% | 895.64K |
Jan 21
| |||||||
Apellis Pharmaceuticals, Inc.
|
0
|
$34.14 | -$393,375.00 |
—
| 869.59K |
Jun 24
| |||||||
Apellis Pharmaceuticals, Inc.
|
0
|
$25.04 | -$279,562.50 |
—
| 869.59K |
May 24
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.